A study to evaluate the safety, tolerability and distribution of TB0010 in head and neck squamous cell carcinoma

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-517779-19-00

Acronym

TB-H-01

Enrollment

Registered

2024-10-22

Start date

2024-01-05

Completion date

2025-12-01

Last updated

2025-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

EGFR-Positive Head and Neck Squamous Cell Carcinoma

None listed

Sex/Gender

All

Age

18 Years to No maximum

Finland

None listed

Source: EU CTIS · Data processed: Feb 4, 2026